Form 4 for TWST Twist Bioscience Corp
Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-04 · accession 0001214659-21-010285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-06 | 2021-10-04 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $23.28 | +2,702 | 39.9K | +7% | +$62.9K |
| D | 2021-10-06 | 2021-10-04 | TWST | Finn Patrick John | Chief Commercial Off | F - Tax | $105.50 | -257 | 39.6K | -0.6% | -$27.1K |
| D | 2021-10-06 | 2021-10-04 | TWST | Finn Patrick John | Chief Commercial Off | S - Sale+OE | $104.27 | -2,702 | 39.6K | -6% | -$281.7K |
| DM | 2021-10-06 | 2021-10-04 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $0.00 | -2,702 | 15.3K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | M | A | 1,517 | $26.66 | 41,441 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-04 | M | A | 827 | $23.33 | 42,268 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-04 | M | A | 358 | $8.82 | 39,924 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-04 | F | D | 257 | $105.50 | 39,566 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
| 5 | Common | Common Stock | 2021-10-04 | S | D | 2,702 | $104.27 | 39,566 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-10-04 | M | D | 1,517 | $0.00 | 37,925 | D | $26.66 · — to 2028-11-18 | 1,517 Common Stock | (F4) 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-10-04 | M | D | 827 | $0.00 | 20,686 | D | $23.33 · — to 2029-10-23 | 827 Common Stock | (F5) 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-10-04 | M | D | 358 | $0.00 | 15,267 | D | $8.82 · — to 2027-09-28 | 358 Common Stock | (F3) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |